EAU 2014 - Poster: Consistent long-term efficacy and safety of onabotulinumtoxinA in patients with neurogenic detrusor overactivity: Final results of repeated treatments up to 4 years

STOCKHOLM, SWEDEN (UroToday.com) - Presented by Gilles Karsenty,1 Heinrich Schulte-Baukloh,2 Roger Dmochowski,3 Karen Ethans,4 Brenda Jenkins,5 Steven Guard,6 Ho-Jin Lee,7 Michael Kennelly8 at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.

Poster-693 EAU thumb

1Aix-Marseille Université, Marseille, France; 2St. Hedwig-Krankenhaus, Berlin, Germany; 3Vanderbilt University Medical Center, Nashville, TN, USA; 4University of Manitoba, Winnipeg, Canada; 5Allergan, Inc., Irvine, CA, USA; 6Allergan, Ltd., Marlow, UK; 7Allergan, Inc., Bridgewater, NJ, USA; 8Carolinas Medical Center, Charlotte, NC, USA

 

email news signup